NBGI Ventures

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

EPIX Therapeutics, Inc. is a medical device company focused on developing innovative temperature-sensing irrigated radiofrequency ablation catheters for treating atrial fibrillation and other cardiac arrhythmias. The company utilizes its proprietary TempaSure technology, which employs microwave radiometry to provide real-time assessment of temperature within the heart, allowing physicians to accurately control lesion formation and enhance clinical outcomes. Founded in 2007 and headquartered in Santa Clara, California, EPIX Therapeutics was previously known as Advanced Cardiac Therapeutics, Inc. and rebranded in August 2018. The company has established strategic partnerships with industry leaders, including Abbott Laboratories and Hansen Medical Inc., to further advance its catheter-based systems aimed at improving the management of irregular heart rhythms. EPIX Therapeutics operates as a subsidiary of Medtronic plc.

DYSIS Medical Ltd., established in 2002 and headquartered in Edinburgh, UK, specializes in designing, developing, manufacturing, and marketing non-invasive imaging systems for detecting cancerous and pre-cancerous lesions. Its flagship product is the DYSIS Colposcope, a digital colposcope that measures aceto-whitening reaction and generates an intuitive map for easier diagnosis. The company also offers accessories like disposable/reusable specula, diathermy loops, coagulation balls, and software for data management and DYSISmap development. With sales offices in Tampa (USA), Edinburgh (UK), and Athens (Greece), DYSIS Medical aims to improve healthcare outcomes globally.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Cellnovo is a medical device company focused on diabetes management. The company develops and markets an integrated system that connects various components of diabetes care through mobile technology. Its product portfolio includes a cordless micro-pump, an integrated monitoring device, and a cellular handset equipped with a touch screen and an embedded blood glucose meter. This innovative system allows for automatic data transmission, enabling patients and healthcare providers to effectively monitor the patient's condition in real-time.

Estech, founded in 1996 by Arthur and Raymond Bertolero, is a privately held medical device manufacturing and distribution company based in San Ramon, California. The company specializes in developing and marketing medical devices and disposables for cardiac surgery, with a focus on least invasive products. Estech's global distribution network and commitment to innovation have attracted top professionals in the medical device industry. The company's success is attributed to the extensive experience and dedication of its team, which has enabled it to thrive in the competitive medical device market.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Symetis is a Swiss company based in Ecublens that specializes in developing innovative minimally invasive heart valve replacement therapies. The company focuses on improving patient care and safety through its proprietary Acurate™ Aortic Valve Replacement System, which features a unique self-positioning design. This design allows for easier implant positioning and alignment, enhancing the overall user experience for healthcare providers. Symetis aims to address the needs of patients suffering from aortic valve stenosis, enabling the effective treatment of severe cardiac valve conditions through its advanced transcatheter aortic valve implantation devices.

Reverse Medical is a commercial-stage medical device company dedicated to the development of innovative solutions for neurovascular disorders, particularly in the management of acute ischemic strokes. The company specializes in creating embolic protection systems designed to enhance the revascularization process for patients experiencing these critical conditions. By concentrating on endovascular treatment options, Reverse Medical aims to improve patient outcomes and streamline interventions for stroke care, positioning itself as a key player in the medical technology sector.

EPIX Therapeutics, Inc. is a medical device company focused on developing innovative temperature-sensing irrigated radiofrequency ablation catheters for treating atrial fibrillation and other cardiac arrhythmias. The company utilizes its proprietary TempaSure technology, which employs microwave radiometry to provide real-time assessment of temperature within the heart, allowing physicians to accurately control lesion formation and enhance clinical outcomes. Founded in 2007 and headquartered in Santa Clara, California, EPIX Therapeutics was previously known as Advanced Cardiac Therapeutics, Inc. and rebranded in August 2018. The company has established strategic partnerships with industry leaders, including Abbott Laboratories and Hansen Medical Inc., to further advance its catheter-based systems aimed at improving the management of irregular heart rhythms. EPIX Therapeutics operates as a subsidiary of Medtronic plc.

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Estech, founded in 1996 by Arthur and Raymond Bertolero, is a privately held medical device manufacturing and distribution company based in San Ramon, California. The company specializes in developing and marketing medical devices and disposables for cardiac surgery, with a focus on least invasive products. Estech's global distribution network and commitment to innovation have attracted top professionals in the medical device industry. The company's success is attributed to the extensive experience and dedication of its team, which has enabled it to thrive in the competitive medical device market.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

EOS Imaging SA is a medical technology company based in Paris, France, specializing in low-dose 2D/3D imaging and software solutions for osteo-articular conditions and orthopedic surgeries. The company develops and markets the EOS imaging system, which produces full-body, stereo-radiographic images of patients in functional positions, tailored to the specific needs of orthopedic surgeons and radiologists. Its product offerings include EOSedge, a high-quality X-ray system, sterEOS, a 3D modeling workstation for precise skeletal analysis, and EOSapps, online surgical planning solutions based on real-time imaging. Additionally, EOS Imaging creates planning software for knee and hip surgeries and manufactures patient-specific cutting guides for orthopedic procedures. The company operates globally, with a presence in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America, and has obtained marketing authorization for its systems in 48 countries. Founded in 1989, EOS Imaging was previously known as biospace med before rebranding in 2010.

20/10 Perfect Vision has develops, manufactures and markets innovative technologies for raising refractive surgery well beyond current expectations. The company's FEMTEC femtosecond laser workstation is set to revolutionize the ophthalmic surgery market, while keeping ease-of-use and patient safety as primary objectives.

BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Direct Energie is a major player in the electricity and gas market, present in France and Belgium. Direct Energie provides the individuals who have, since the opening of the market in 2007, made the choice of an alternative energy supplier. Also, Direct Energie provides nearly 260,000 professional customers (craftsmen, tradesmen, freelancers) and businesses, regardless of the number of sites (SMEs, retail networks, bank branches or relay offices), as well as consumers. industrial. Moreover, Direct Energie currently supplies nearly 100,000 municipalities and communities in France. The Group is steadily strengthening its position in this customer segment with, in particular, the signing of a contract with SIPPEREC (Syndicat Intercommunal de la Périphérie de Paris for Electricity and Communication Networks), the SDEC (Syndicat Intercommunal de Paris). energies of Calvados), the Métropole de Grenoble or public institutions such as the Grand Port Maritime du Havre.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.